Therefore, the artificial elongation of tumor-associated CD8+ Tcell epitopes or the application of multivalent long peptides comprising at the same time CD4+ and CD8+ T cell epitopes displays promising attempts to improve the efficacy and clinical outcome of peptide vaccination (58, 59, 60, 61, 62, 63). This evidence concerns the gene CD8A and neoplasm.